top of page
  • hope4atrt

Dr. Trisha Larkin is dual-board certified in Pediatrics and Pediatric Hematology-Oncology with an expertise in Pediatric Neuro-Oncology. She serves as the Director of Pediatric Neuro-Oncology at St. Joseph’s Children’s Hospital in Tampa, FL.

Dr. Larkin’s career is dedicated towards expanding clinical growth, research, and clinical trial offerings for children battling central nervous system tumors. Dr. Larkin earned her medical degree from Florida International University in Miami, followed by a Master of Business Administration with a focus in healthcare. She completed her postdoctoral pediatric training at Nicklaus Children’s Hospital, followed by a fellowship in pediatric hematology-oncology and bone marrow transplantation at the University of Florida in Gainesville. She then completed an advanced fellowship in Pediatric Neuro-oncology at St. Jude Children’s Research Hospital in Memphis, Tennessee where she worked on a team of world-renowned physicians and researchers to care for children diagnosed with complex brain and spinal tumors.

Dr. Larkin is passionate about discovering innovative strategies to improve the care of children with brain tumors. Her research interests include early-phase clinical trials and drug development. Dr. Larkin has presented her research in pediatric central nervous system tumors at national and international meetings across the states as well as in Karuizawa, Japan and Hamburg, Germany. Dr. Larkin has published numerous peer-reviewed articles in prestigious journals such as the Journal of Clinical Oncologyand Neuro-Oncology. She serves as associate editor for Neuro-Oncology on the MedNet, an interactive platform for physicians around the world to gather insight about treating complex oncologic diagnoses. She is a member of the American Society of Pediatric Hematology-Oncology, Society for Neuro-Oncology, Children’s Oncology Group, Society for Pediatric Research, American Society of Clinical Oncology, and American Academy of Pediatrics.


Updated: May 25, 2023

We are excited to announce that this week, we will be collaborating with Lantern Pharma for #BrainTumorAwarenessMonth in an effort to continue our mission of spreading awareness and information about ATRT.

We recently met Lantern at the American Association for Cancer Research (AACR) annual meeting where we learned about their commitment to supporting the ATRT cancer community and how they are using AI to help develop novel drugs for ATRT and other pediatric brain cancers. Learn more about Lantern by visiting their website or vising their social channels Lantern Pharma Inc | LinkedIn & @LanternPharma | Twitter


[Video] ATRT Facts


[Video] Drug Facts

Did you know – There have been NO drugs developed and approved specifically to treat malignant pediatric brain tumors like ATRT?

An urgent and unmet need is for the development of safe and effective cancer treatment options.

Lantern and their subsidiary Starlight Therapeutics are committed to shifting the narrative for drug development for pediatric brain tumor patients. One way they are doing this is by leveraging AI to help develop novel and effective therapies to help create meaningful change for these patients.


Zion's courageous battle gives us the drive to make a difference for the next child.


Today we are sharing the Angel story of Zion Yamoah, the son of Hope4ATRT Foundation founders, to honor his legacy and to support all the other incredible children who are fighting battles with ATRT.

His story reminds us of the challenges that ATRT patients face and the importance of our efforts to develop therapies to help fight this very rare and aggressive #braintumor.

Learn more about Zion’s story and the Yamoah family’s journey at:

  • hope4atrt

Amie Marzen is the mom of ATRT angel Madeline, and founder of Madeline's Mission.

A silly, sweet, loving child, Madeline spread joy to all who knew her. She was always quick to give a hug or share a silly song. Madeline was diagnosed with AT/RT three weeks before her 4th birthday and fought hard to stay with her family and friends, however she passed away just two short months after diagnosis.

As her family and friends began to grieve the loss of this bright light, it became apparent the need to help fill in the gaps in care surrounding the loss of a child. In her memory, Madeline’s Mission was formed to help share the kindness Madeline spread throughout her short life– and help provide hope to families surviving child loss.

For additional bereaved resources, visit:

bottom of page